ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Stock Income Statement
USA - NASDAQ:ADAP - US00653A1079 - ADR
0.0549 USD
-0.01 (-15.15%)
0.0579 USD
+0 (+5.46%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 65.08M | 178.03M | 60.28M | 27.15M | 6.15M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | 70.00K | null | null | null | |||
| Gross Profit | null | 177.96M | null | null | null | |||
| Operating Expenses | 207.09M | 230.37M | 190.97M | 188.81M | 168.40M | |||
| Research and Development | 125.24M | 149.06M | 126.51M | 127.73M | 111.09M | |||
| Selling, General, and Administrative Expenses | 82.03M | 81.31M | 64.46M | 61.09M | 57.31M | |||
| Operating Income | -145.46M | -52.41M | -130.69M | -161.67M | -162.25M | |||
| Interest Income/Expense | -647.00K | 3.25M | 5.96M | 1.54M | 1.10M | |||
| Other Income/Expense | -1.18M | -1.73M | -807.00K | -540.00K | 3.85M | |||
| Non Recurring Items | -18.77M | -16.35M | 13.00M | -2.30M | null | |||
| Income Before Taxes | -166.04M | -67.24M | -112.53M | -162.96M | -157.30M | |||
| Income Tax | 3.71M | 3.58M | 1.34M | 2.50M | 790.00K | |||
| Net Income | -169.76M | -70.81M | -113.87M | -165.46M | -158.09M | |||
| EBITDA | -134.83M | -41.18M | -120.85M | -155.59M | -155.68M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.6570006244444477 | -0.27977824589627076 | -0.5643390259104264 | -1.0162885000505562 | -1.0162885000505562 | |||
| Non GAAP EPS | -0.45999999999999996 | -0.19 | -0.664 | -1 | -1.02 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 99.96% | N/A | N/A | N/A | |||
| Profit Margin | -260.82% | -39.78% | -188.90% | -609.43% | -2570.57% | |||
| Operating Profit Margin | -223.48% | -29.44% | -216.80% | -595.47% | -2638.21% | |||
All data in USD